Cargando…
Anakinra treatment for refractory cerebral autoinflammatory responses
Refractory cerebral autoinflammatory–autoimmune diseases are often associated with dysregulated innate immunity and are targeted by anakinra, an interleukin‐1 receptor antagonist. We analyzed the therapeutic effect of anakinra in refractory cerebral autoinflammatory response (CAIR) at a single insti...
Autores principales: | Jang, Yoonhyuk, Lee, Woo‐Jin, Lee, Han Sang, Chu, Kon, Lee, Sang Kun, Lee, Soon‐Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791800/ https://www.ncbi.nlm.nih.gov/pubmed/35040583 http://dx.doi.org/10.1002/acn3.51500 |
Ejemplares similares
-
Cerebral autoinflammatory disease treated with anakinra
por: Jang, Yoonhyuk, et al.
Publicado: (2018) -
Botulinum toxin treatment for hypersalivation in anti‐NMDA receptor encephalitis
por: Jun, Jin‐Sun, et al.
Publicado: (2017) -
A Psychiatric Side Effect of Levetiracetam Can Mimic a Relapse of Anti-Leucine-Rich Glioma Inactivated 1 Encephalitis
por: Jang, Yoonhyuk, et al.
Publicado: (2018) -
Rituximab Treatment for Idiopathic Hypertrophic Pachymeningitis
por: Jang, Yoonhyuk, et al.
Publicado: (2017) -
Telemedicine in epilepsy and encephalitis: previous research and indication guidelines in Korea
por: Jang, Yoonhyuk, et al.
Publicado: (2022)